Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

The lymphatic vasculature transports extravasated tissue fluid, macromolecules and cells back into the blood circulation. Recent reports have focused on the molecular mechanisms regulating the lymphatic vessels. Vascular endothelial growth factor (VEGF)-C and VEGF-D have been shown to stimulate lymp...

Full description

Bibliographic Details
Main Authors:	Mäkinen, T, Jussila, L, Veikkola, T, Karpanen, T, Kettunen, M, Pulkkanen, K, Kauppinen, R, Jackson, D, Kubo, H, Nishikawa, S, Ylä-Herttuala, S, Alitalo, K
Format:	Journal article
Language:	English
Published:	2001

Similar Items

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
by: Yoon, Y, et al.
Published: (2003)

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
by: Enholm, B, et al.
Published: (2001)

VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
by: Mattila, M, et al.
Published: (2002)

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
by: Skobe, M, et al.
Published: (2001)

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.
by: Cursiefen, C, et al.
Published: (2004)

Lymphangiogenesis in melanoma, squamous cell carcinoma and breast carcinoma
by: Skobe, M, et al.
Published: (2001)

Hyaluronan and lymphedema.
by: Jackson, D
Published: (2004)

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.
by: Mandriota, S, et al.
Published: (2001)

Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.
by: Hawighorst, T, et al.
Published: (2002)

Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival
by: Cursiefen, C, et al.
Published: (2004)

Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.
by: Cursiefen, C, et al.
Published: (2004)

Breast cancer related lymphedema
by: Haen, R
Published: (2012)

Complete inhibition of simultaneous onset corneal lymphangiogenesis and angiogenesis by trapping vascular endothelial growth factor (VEGF) using a VEGF receptor 1 and 2 chimeric protein (VEGF TrapR1R2)
by: Cursiefen, C, et al.
Published: (2003)

Regulation of utrophin in transgenic mice.
by: Davies, K
Published: (2005)

FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.
by: Kriederman, B, et al.
Published: (2003)

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
by: Stacker, SA, et al.
Published: (2001)

Health workers' agreement in clinical description of filarial lymphedema.
by: Mcpherson, T, et al.
Published: (2006)

Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
by: Cursiefen, C, et al.
Published: (2005)

Lymphangiogenesis and metastasis in malignant melanoma
by: Shields, J, et al.
Published: (2003)

Role of lymphangiogenesis in epithelial ovarian cancer.
by: Sundar, S, et al.
Published: (2006)

Effects of secreted macrophage scavenger receptor on atherogenesis and lipoprotein metabolism in LDL receptor knockout mice
by: Laukkanen, J, et al.
Published: (1999)

Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice.
by: Jalkanen, J, et al.
Published: (2003)

Regulation of utrophin in transgenic mice (multiple letters)
by: Davies, K, et al.
Published: (2005)

T helper cell unresponsiveness: rapid induction in antigen-transgenic and reversion in non-transgenic mice.
by: Bachmann, M, et al.
Published: (1994)

Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis.
by: Miotla, J, et al.
Published: (2000)

Cooperative Effects of Vascular Angiogenesis and Lymphangiogenesis
by: Osaki, Tatsuya, et al.
Published: (2021)

Immunohistochemical methods for measuring tissue lymphangiogenesis.
by: Clasper, S, et al.
Published: (2009)

Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
by: Garcia de la Torre, N, et al.
Published: (2004)

Identification of the transgenic integration site in 2C T cell receptor transgenic mice
by: Son, Chae-Yeon, et al.
Published: (2022)

Identification of the transgenic integration site in 2C T cell receptor transgenic mice
by: Son, Chae-Yeon, et al.
Published: (2021)

Increased endothelial tetrahydrobiopterin levels in GTPCH-transgenic mice
by: Alp, N, et al.
Published: (2002)

Molecular characterization of dermal lymphatic endothelial cells from primary lymphedema skin.
by: Ogunbiyi, S, et al.
Published: (2011)

Tissue-specific targeting of cytokine unresponsiveness in transgenic mice.
by: Dighe, A, et al.
Published: (1995)

Transgenic approaches to the study of neural development in mice
by: Fesenko, John, 1968-
Published: (2008)

Generation of transgenic mice with yeast artificial chromosomes.
by: Montoliu, L, et al.
Published: (1993)

Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
by: Brownlees, J, et al.
Published: (1997)

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
by: Jackson, D, et al.
Published: (2001)

New molecular markers for the study of tumour lymphangiogenesis.
by: Jackson, D
Published: (2001)

Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice.
by: Mamalaki, C, et al.
Published: (1992)

Point cloud alignment in arm reconstruction for lymphedema detection by iterating pairwise ICP
by: Yordán López, Fernando A.
Published: (2019)